Stevens Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$45.7M |
| 2 |
Amgen
AMGN
|
+$38.7M |
| 3 |
Pfizer
PFE
|
+$34.2M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$32.8M |
| 5 |
Chevron
CVX
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$41.7M |
| 2 |
CELG
Celgene Corp
CELG
|
+$41.3M |
| 3 |
Micron Technology
MU
|
+$35M |
| 4 |
General Dynamics
GD
|
+$34.3M |
| 5 |
Altria Group
MO
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.47% |
| 2 | Healthcare | 13.96% |
| 3 | Industrials | 11.37% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Technology | 9.91% |
Similar funds
Stevens Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Stevens Capital Management held 1,429 positions worth $2.78B, down 1.2% from $2.81B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Stevens Capital Management deployed $103M of net new capital in Q2 2015, opening 471 new positions and adding to 293 existing holdings. Its largest new stake was Verizon: 934,377 shares worth $43.6M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Altria Group, an estimated $27.8M trimmed.
- Stevens Capital Management's largest Q2 2015 buy was Verizon: 934,377 shares worth $43.6M.
- Stevens Capital Management added most to Amgen in Q2 2015, an estimated $38.7M increase.
- Stevens Capital Management's biggest Q2 2015 reduction was Altria Group, cutting an estimated $27.8M.
- Stevens Capital Management fully exited Procter & Gamble in Q2 2015, selling an estimated $41.7M.
- Stevens Capital Management's ten largest holdings make up 12% of its $2.78B portfolio in Q2 2015.
- Stevens Capital Management opened 471 new positions and closed 447 in Q2 2015.
- Stevens Capital Management's portfolio value fell 1.2% quarter-over-quarter to $2.78B.
Based on Stevens Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.